Groundbreaking science with the potential to cause a seismic shift in disease treatment.
Proven leadership team with the business and scientific acumen to create value.
Critical alignment with corporate and scientific partners to validate and unlock the value of the Permeon advantage.
Proprietary Intraphilin™ Technology Platform enables existing biologics to function in cells and treat disease.
